Are the First and Second Hip in Staged Bilateral Total Hip Arthroplasty Equal? A Hospital Adverse Event and Perioperative Risk Comparison

Abstract

Hospital adverse events remain a significant issue; even “minor events” may lead to increased costs. However, to the best of our knowledge, no previous investigation has compared perioperative events between the first and second hip in staged bilateral total hip arthroplasty (THA). In the current study, we perform such a comparison. A retrospective chart review was performed on a consecutive series of 172 patients (344 hips) who underwent staged bilateral THAs performed by two surgeons at a single institution (2010–2016). Based on chronological order of the staged arthroplasties, two groups were set apart: first-staged THA and second-staged THA. Baseline-demographics, length of stay (LOS), discharge disposition, hospital adverse events, and hospital transfusions were compared between groups. Statistical analyses were performed using independent t-tests, Fisher's exact test, and/or Pearson's chi-squared test. The mean time between staged surgeries was 465 days. There were no significant differences in baseline demographics between first-staged THA and second-staged THA groups (patients were their own controls). The mean LOS was significantly longer in the first-staged THA group than in the second (2.2 vs. 1.8 days; p < 0.001). Discharge (proportion) to a facility other than home was noticeably higher in the first-staged THA group, although not statistically significant (11.0 vs. 7.6%; p = 0.354). The rate of hospital adverse events in the first-staged THA group was almost twice that of the second (37.2 vs. 20.3%; p = 0.001). There were no significant differences in transfusion rates. However, these were consistently better in the second-staged THA group. When compared with the first THA, our findings suggest overall shorter LOS and fewer hospital adverse events following the second.

Level of Evidence Level III.

Keywords

hospital adverse events - bilateral total hip arthroplasty - perioperative outcomes - staged - first hip - second hip

Publication History

Received: 17 April 2020

Accepted: 25 January 2021

Article published online:
15 June 2021

• References

• 1 Lindberg-Larsen M, Joergensen CC, Husted H, Kehlet H. Simultaneous and staged bilateral total hip arthroplasty: a Danish nationwide study. Arch Orthop Trauma Surg 2013; 133 (11) 1601-1605
• 2 Sah DRK, Sarfraz DAH. Comparative study of simultaneous and staged bilateral non-cemented total hip replacement in young active adults in terms of cost effectiveness and improvements in Harris hip score. Int J Orthop Sci 2018; 4: 935-938
• 3 Kim SC, Lim YW, Jo WL. et al. Surgical accuracy, function, and quality of life of simultaneous versus staged bilateral total hip arthroplasty in patients with Osteonecrosis of the femoral head. BMC Musculoskelet Disord 2017; 18 (01) 266 DOI: 10.1186/s12891-017-1605-2.
• 4 Martin GR, Marsh JD, Vasarhelyi EM, Howard JL, Lanting BA. A cost analysis of single-stage bilateral versus two-stage direct anterior total hip arthroplasty. Hip Int 2016; 26 (01) 15-19
• 5 Rasouli MR, Maltenfort MG, Ross D, Hozack WJ, Memtsoudis SG, Parvizi J. Perioperative morbidity and mortality following bilateral total hip arthroplasty. J Arthroplasty 2014; 29 (01) 142-148
• 6 Kamath AF, Monteiro EL, Spranger A, Impellizzeri F, Leunig M. Simultaneous versus staged bilateral direct anterior total hip arthroplasty: are early patient-centered outcomes equivalent?. Acta Orthop Belg 2016; 82 (03) 497-508
• 7 Culler SD, Jevsevar DS, McGuire KJ, Shea KG, Little KM, Schlosser MJ. Predicting the incremental hospital cost of adverse events among Medicare beneficiaries in the comprehensive joint replacement program during fiscal year 2014. J Arthroplasty 2017; 32 (06) 1732-1738.e1
• 8 Culler SD, McGuire KJ, Little KM. et al. Incremental hospital cost and length-of-stay associated with treating adverse events among Medicare beneficiaries undergoing cervical spinal fusion during fiscal year 2013 and 2014. Spine 2017; 42 (20) 1578-1586
• 9 Higuera CA, Elsharkawy K, Klika AK, Brocone M, Barsoum WK. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res 2011; 469 (05) 1391-1400
• 10 Pulido L, Parvizi J, Macgibeny M. et al. In hospital complications after total joint arthroplasty. J Arthroplasty 2008; 23 (06, Suppl 1): 139-145
• 11 Guenther D, Schmidl S, Klatte TO. et al. Overweight and obesity in hip and knee arthroplasty: evaluation of 6078 cases. World J Orthop 2015; 6 (01) 137-144
• 12 Schaeffer JF, Scott DJ, Godin JA, Attarian DE, Wellman SS, Mather III RC. The association of ASA class on total knee and total hip arthroplasty readmission rates in an academic hospital. J Arthroplasty 2015; 30 (05) 723-727
• 13 Hart A, Antoniou J, Brin YS, Huk OL, Zukor DJ, Bergeron SG. Simultaneous bilateral versus unilateral total knee arthroplasty: a comparison of 30-day readmission rates and major complications. J Arthroplasty 2016; 31 (01) 31-35
• 14 Morcos MW, Hart A, Antoniou J, Huk OL, Zukor DJ, Bergeron SG. No difference in major complication and readmission rates following simultaneous bilateral vs unilateral total hip arthroplasty. J Arthroplasty 2018; 33 (08) 2541-2545
• 15 Sutton III JC, Antoniou J, Epure LM, Huk OL, Zukor DJ, Bergeron SG. Hospital discharge within 2 days following total hip or knee arthroplasty does not increase major-complication and readmission rates. J Bone Joint Surg Am 2016; 98 (17) 1419-1428